Results 81 to 90 of about 15,817 (194)

Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B [PDF]

, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/98397/1/apt12344 ...
Beasley, Bruix, Chen, El-Serag, Fattovich, Fattovich, Fattovich, Fattovich, Fattovich, Heathcote, Hosaka, Inoue, Kobashi, Koklu, Lai, Liaw, Liaw, Lok, Papatheodoridis, Papatheodoridis, Sherman, Simonetti, Singal, Ulm, Yang, Yang   +25 more
core   +1 more source

A systematic review of medication adherence and mortality in chronic disease: Implications for clinical guidelines and policy

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 360-373, February 2026.
Objectives This systematic review aims to investigate whether good medication adherence in adults with chronic conditions is associated with a lower mortality risk compared to poor adherence within published literature, and the extent to which this relationship is represented within South African policy and legislation.
Jessica Hamuy Blanco, Dina C. Janse van Rensburg, Audrey Jansen van Rensburg, Corrie Uys, Natalie Schellack   +4 more
wiley   +1 more source

Effect and safety analysis of Yiqi Yangxue Jiedu decoction combined with entecavir in the treatment of male patients with decompensated hepatitis B cirrhosis [PDF]

Journal of Men's Health
Background: This study aimed to evaluate the efficacy and safety of Yiqi Yangxue Jiedu Decoction & Entecavir in male patients with decompensated hepatitis B cirrhosis.
Mingli Jia
doaj   +1 more source

Strangers in the night:a comparative study on the socio-legal difficulties of importing America’s Bayh-Dole legislation to South African universities [PDF]

, 2019
In 2008, the South African parliament passed the Intellectual Property Rights from Publicly Financed Research and Development Act, which came into effect on 2 August 2010.
Kouletakis, Jade
core  

Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials [PDF]

, 2012
Background The studies on the effectiveness of Chinese herbal medicines (CHM) in treating liver fibrosis (LF) were not consistent. This study aims to systematically review the effectiveness of CHM on treating LF patients.
Fan Cheung, Yibin Feng, Ning Wang, Man-Fung Yuen, Yao Tong, Vivian Wong   +5 more
core   +2 more sources

Three‐Year Long‐Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Findings regarding long‐term outcomes of unresectable hepatocellular carcinoma (uHCC) patients treated with atezolizumab and bevacizumab (Atez/Bev) have yet to be reported. This study was performed to evaluate results regarding 3 year survival of such patients treated in real‐world clinical settings.
Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Teruki Miyake, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +55 more
wiley   +1 more source

Virologic response and safety of tenofovir versus entecavir in treatment-naïve chronic Hepatitis B patients

The Saudi Journal of Gastroenterology, 2015
Background/Aims: This study aimed to evaluate the antiviral response and safety of tenofovir (TDF) versus entecavir (ETV) in treatment-naïve CHB patients. Patients and Methods: We performed a retrospective cohort study of treatment-naive CHB patients who
Hyung Min Yu, So Young Kwon, Jiwan Kim, Hyun Ah Chung, Se Woong Kwon, Taek Gun Jeong, Sang Hee An, Gyung Won Jeong, Seon Ung Yun, Jae Ki Min, Jeong Han Kim, Won Hyeok Choe   +11 more
doaj   +1 more source

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection [PDF]

, 2013
Introduction: Resistance in nucleoside/nucleotide analog (NA) therapy has always been a challenge in the management of chronic hepatitis B (CHB). Clinical studies: Initially developed for the treatment of HIV infection, early in vitro and clinical ...
Fung, J, Lai, CL, Seto, WK, Yuen, MF
core   +1 more source

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation [PDF]

, 2015
The copyright line for this article was changed on 18 November 2016 after original online publication. Abbreviations: CEAF cost-effectiveness frontier. CHB chronic hepatitis B. CI confidence intervals.
Burroughs, AK, Crossan, C, Davidson, B, Gurusamy, K, Longworth, L, Mantzoukis, K, Noel-Storr, A, O'Brien, J, Papastergiou, V, Papatheodoridis, GV, Rodriguez-Peralvarez, M, Thalassinos, E, Tsochatzis, EA   +12 more
core   +2 more sources

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment [PDF]

, 2011
Aim Currently, there is no consensus on the retreatment recommendation of chronic hepatitis B (CHB) patients with viral rebound after cessation of treatment.
Zhao Wang, Xiao-Ling Wu, Wei-Zheng Zeng, Hui Xu, Yong Zhang, Jian-Ping Qin, Ming-De Jiang   +6 more
core   +2 more sources